Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease

摘要

Transdermal pharmaceutical preparations for the treatment of Parkinson's disease containing a combination of at least two active substances selected from the following groups of active substances: dopamine agonists and L-dopa, monoamine oxidase inhibitors, anticholinergics, NMDA-receptor antagonists, sympathomimetics; at least two of the said active substances being members of different active substance groups.